TD Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.8M Buy
320,547
+128,047
+67% +$13.1M 0.03% 393
2026
Q2
$19.1M Buy
+192,500
New +$17.3M 0.02% 515

Other funds holding IHE

TD Asset Management's IHE Position: Q3 2026 in Review

TD Asset Management increased its iShares US Pharmaceuticals ETF (IHE) stake by 67% in Q3 2026, buying an estimated $13.1M and bringing the position to 320,547 shares worth $32.8M. The position accounts for 0.03% of the portfolio, ranked #393.

TD Asset Management first reported a position in IHE in Q2 2026 and has held it in 2 quarters since. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • TD Asset Management held 320,547 shares of iShares US Pharmaceuticals ETF worth $32.8M as of Q3 2026.
  • TD Asset Management bought 128,047 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $13.1M.
  • iShares US Pharmaceuticals ETF made up 0.03% of TD Asset Management's portfolio in Q3 2026, its #393 holding.
  • TD Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2026 and has held it in 2 quarters since.
  • 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.